Inclusion criteria | Exclusion criteria |
---|---|
Adult male or female, 40 years of age or over (until 86 years old) | Participants that do not sign the informed consent |
TcPO2 ≤ 30 mmHg | Presence of osteomyelitis |
Diagnosis of diabetes | Hemodynamic instability (MAP < 65 mmHg or vasopressor requirement) |
Patients with signs of critical ischemia such as: | Any acute systemic infectious disease process |
Ulcer that does not heal | |
Necrosis or loss of tissue | |
Pain at rest | |
Intermittent claudication | |
Basal Rutherford classification stage 3 to 5 | Severe sepsis |
Non-revascularized patients due to comorbidities and/or anatomy | Uncontrolled coagulopathy |
Patients that despite revascularization (vascular surgery) have adequate distal beds to perfuse the limb | Condition of cancer |
Ankle/brachial index less than 0.4 | Use of immunosuppressive or cytotoxic drugs |
Stenosis or occlusion of the infrapatellar arteries | Alterations of the bone marrow that do not allow the adequate extraction of the components to be used as: acute leukemia, chronic leukemia, marrow aplasia, myelodysplastic syndrome, and myelophthisis |
Contraindication of sedation for bone marrow aspirate | |
Patients who have suffered in a period < six months of myocardial infarction, disease cerebrovascular or coronary intervention | |
Patients with liver failure indicated by serum transaminases (aspartate aminotransferase and alanine aminotransferase), with values twice the normal limit | |
Any acute or chronic contagious disease including hepatitis B, hepatitis C, and HIV | |
Any other comorbidity that the treating vascular surgeon considers as a contraindication to cell treatments |